<p><img src="https://imageproxy.pbkrs.com/https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2026/03/PT-13-03-2026-shutterstock_2557731283-430x241.jpg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" width="430" height="241" original-src="https://imageproxy.pbkrs.com/https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2026/03/PT-13-03-2026-shutterstock_2557731283-430x241.jpg"/></p>
<p>公用規模的量子計算機預計將能夠以高效的方式實現化學精確的分子模擬。圖片來源：Gorodenkoff / Shutterstock.com。</p>
<p>PsiQuantum 與日本國立癌症中心簽署了合作研究協議，以推動公用規模量子計算在藥物發現和腫瘤學領域的進展。</p>
<p>該合作旨在研究如何在醫療價值鏈中實施量子計算解決方案，重點關注資源分配、研發和癌症護理中的患者結果。</p>
<h3>深入瞭解 GlobalData</h3>
<ul>
<li><img src="/wp-content/themes/goodlife-wp-B2B/assets/img/report.png" alt="ReportsLogo" original-src="/wp-content/themes/goodlife-wp-B2B/assets/img/report.png"/></li>
</ul>
<p>報告</p>
<h4>LOA 和 PTSR 模型 - CDK-002 在頭頸癌鱗狀細胞中的應用...</h4>
<ul>
<li><img src="/wp-content/themes/goodlife-wp-B2B/assets/img/report.png" alt="ReportsLogo" original-src="/wp-content/themes/goodlife-wp-B2B/assets/img/report.png"/></li>
</ul>
<p>報告</p>
<h4>LOA 和 PTSR 模型 - CDK-002 在三陰性乳腺癌（TNBC）中的應用</h4>
<h5>深入瞭解 GlobalData</h5>
<p>商業智能的黃金標準。</p>
<p>瞭解更多</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.pharmaceutical-technology.com/wp-content/themes/goodlife-wp-B2B/assets/images/GMS-logo.svg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.pharmaceutical-technology.com/wp-content/themes/goodlife-wp-B2B/assets/images/GMS-logo.svg"/></p>
<h4>發現高效的 B2B 營銷</h4>
<p>結合商業智能和編輯卓越，覆蓋 36 個領先媒體平台的專業人士。</p>
<p>瞭解更多</p>
<p>在此次合作中，PsiQuantum 將與日本國立癌症中心合作，進一步開發容錯量子算法，並共同開發臨牀相關的量子應用。</p>
<p>該計劃還涉及其他日本製藥公司。PsiQuantum 的軟件套件 Construct 將在合作期間使用。</p>
<p>Construct 是一個安全的平台，旨在設計、分析和優化容錯量子計算的算法。</p>
<p>公用規模的量子計算機預計將以更高的效率實現化學精確的分子模擬。這一進展可能加速藥物發現過程，降低研究成本，並解決現實世界的醫療挑戰。</p>
<p><img src="/wp-content/themes/goodlife-wp-B2B/assets/images/strategic-int.png" alt="" original-src="/wp-content/themes/goodlife-wp-B2B/assets/images/strategic-int.png"/></p>
<p>GlobalData 戰略情報</p>
<h1>美國關税正在變化 - 你會反應還是預見？</h1>
<p>不要讓政策變化讓你措手不及。通過實時數據和專家分析保持主動。</p>
<p>來自 GlobalData</p>
<p>瞭解更多關於戰略情報</p>
<p>PsiQuantum 量子應用副總裁 Sam Pallister 表示：“PsiQuantum 很自豪能與日本國立癌症中心合作，探索公用規模量子計算在設計新治療方案方面能夠帶來的益處，造福研究人員和患者。</p>
<p>“一旦部署，公用規模的量子計算機將加速研究和開發，改變我們開發新藥物的方式——這樣的合作對於確保提供者能夠充分利用這一技術至關重要。”</p>
<p>日本國立癌症中心醫院東部的全球腫瘤學主任高幸義博士表示：“我們很高興與 PsiQuantum 合作，利用量子計算技術解決醫療領域的一些最緊迫的挑戰。</p>
<p>“我們的團隊將共同開展創新研究，解鎖製藥、生物技術和量子計算交匯處的新解決方案。”</p>

<p>PsiQuantum 已與日本國立癌症中心建立合作關係，以推動藥物發現和腫瘤學領域的實用規模量子計算。該合作旨在在醫療保健中實施量子解決方案，重點關注資源分配和患者結果。PsiQuantum 將開發容錯量子算法和臨牀相關應用，利用其軟件套件 Construct。預計這一合作將增強分子模擬，加速藥物發現，並解決醫療保健挑戰，同時獲得日本其他製藥公司的支持</p>

<p><img src="https://imageproxy.pbkrs.com/https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2026/03/PT-13-03-2026-shutterstock_2557731283-430x241.jpg" alt="" original-src="https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2026/03/PT-13-03-2026-shutterstock_2557731283-430x241.jpg"/></p>
<p>Utility-scale quantum computers are expected to enable chemically accurate molecular simulations with efficiency. Credit: Gorodenkoff / Shutterstock.com.</p>
<div class="lb-trans"><p>公用規模的量子計算機預計將能夠以高效的方式實現化學精確的分子模擬。圖片來源：Gorodenkoff / Shutterstock.com。</p>
</div><p>PsiQuantum and the National Cancer Center Japan have entered a collaborative research agreement to drive advancements in utility-scale quantum computing within drug discovery and oncology.</p>
<div class="lb-trans"><p>PsiQuantum 與日本國立癌症中心簽署了合作研究協議，以推動公用規模量子計算在藥物發現和腫瘤學領域的進展。</p>
</div><p>The partnership aims to investigate ways to implement quantum computing solutions throughout the healthcare value chain, with a focus on resource allocation, research and development, and patient outcomes in cancer care.</p>
<div class="lb-trans"><p>該合作旨在研究如何在醫療價值鏈中實施量子計算解決方案，重點關注資源分配、研發和癌症護理中的患者結果。</p>
</div><h3>Go deeper with GlobalData</h3>
<div class="lb-trans"><h3>深入瞭解 GlobalData</h3>
</div><ul>
<li><img src="/wp-content/themes/goodlife-wp-B2B/assets/img/report.png" alt="ReportsLogo" original-src="/wp-content/themes/goodlife-wp-B2B/assets/img/report.png"/></li>
</ul>
<div class="lb-trans"><ul>
<li><img src="/wp-content/themes/goodlife-wp-B2B/assets/img/report.png" alt="ReportsLogo" original-src="/wp-content/themes/goodlife-wp-B2B/assets/img/report.png"/></li>
</ul>
</div><p>Reports</p>
<div class="lb-trans"><p>報告</p>
</div><h4>LOA and PTSR Model - CDK-002 in Head And Neck Cancer Squamous Cell ...</h4>
<div class="lb-trans"><h4>LOA 和 PTSR 模型 - CDK-002 在頭頸癌鱗狀細胞中的應用...</h4>
</div><ul>
<li><img src="/wp-content/themes/goodlife-wp-B2B/assets/img/report.png" alt="ReportsLogo" original-src="/wp-content/themes/goodlife-wp-B2B/assets/img/report.png"/></li>
</ul>
<div class="lb-trans"><ul>
<li><img src="/wp-content/themes/goodlife-wp-B2B/assets/img/report.png" alt="ReportsLogo" original-src="/wp-content/themes/goodlife-wp-B2B/assets/img/report.png"/></li>
</ul>
</div><p>Reports</p>
<div class="lb-trans"><p>報告</p>
</div><h4>LOA and PTSR Model - CDK-002 in Triple-Negative Breast Cancer (TNBC)</h4>
<div class="lb-trans"><h4>LOA 和 PTSR 模型 - CDK-002 在三陰性乳腺癌（TNBC）中的應用</h4>
</div><h5>Go deeper with GlobalData</h5>
<div class="lb-trans"><h5>深入瞭解 GlobalData</h5>
</div><p>The gold standard of business intelligence.</p>
<div class="lb-trans"><p>商業智能的黃金標準。</p>
</div><p>Find out more</p>
<div class="lb-trans"><p>瞭解更多</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.pharmaceutical-technology.com/wp-content/themes/goodlife-wp-B2B/assets/images/GMS-logo.svg" alt="" original-src="https://www.pharmaceutical-technology.com/wp-content/themes/goodlife-wp-B2B/assets/images/GMS-logo.svg"/></p>
<h4>Discover B2B Marketing That Performs</h4>
<div class="lb-trans"><h4>發現高效的 B2B 營銷</h4>
</div><p>Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.</p>
<div class="lb-trans"><p>結合商業智能和編輯卓越，覆蓋 36 個領先媒體平台的專業人士。</p>
</div><p>Find out more</p>
<div class="lb-trans"><p>瞭解更多</p>
</div><p>Within this collaboration, PsiQuantum will work with the National Cancer Center Japan to further fault-tolerant quantum algorithm development, as well as jointly develop clinically relevant quantum applications.</p>
<div class="lb-trans"><p>在此次合作中，PsiQuantum 將與日本國立癌症中心合作，進一步開發容錯量子算法，並共同開發臨牀相關的量子應用。</p>
</div><p>The initiative also involves other pharmaceutical companies in Japan. PsiQuantum’s software suite, Construct, will be used during the partnership.</p>
<div class="lb-trans"><p>該計劃還涉及其他日本製藥公司。PsiQuantum 的軟件套件 Construct 將在合作期間使用。</p>
</div><p>Construct is a secure platform built for designing, analysing, and optimising algorithms for fault-tolerant quantum computing.</p>
<div class="lb-trans"><p>Construct 是一個安全的平台，旨在設計、分析和優化容錯量子計算的算法。</p>
</div><p>Utility-scale quantum computers are expected to enable chemically accurate molecular simulations with greater efficiency. This advancement could accelerate drug discovery processes, reduce research costs, and address real-world healthcare challenges.</p>
<div class="lb-trans"><p>公用規模的量子計算機預計將以更高的效率實現化學精確的分子模擬。這一進展可能加速藥物發現過程，降低研究成本，並解決現實世界的醫療挑戰。</p>
</div><p><img src="/wp-content/themes/goodlife-wp-B2B/assets/images/strategic-int.png" alt="" original-src="/wp-content/themes/goodlife-wp-B2B/assets/images/strategic-int.png"/></p>
<p>GlobalData Strategic Intelligence</p>
<div class="lb-trans"><p>GlobalData 戰略情報</p>
</div><h1>US Tariffs are shifting - will you react or anticipate?</h1>
<div class="lb-trans"><h1>美國關税正在變化 - 你會反應還是預見？</h1>
</div><p>Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.</p>
<div class="lb-trans"><p>不要讓政策變化讓你措手不及。通過實時數據和專家分析保持主動。</p>
</div><p>By GlobalData</p>
<div class="lb-trans"><p>來自 GlobalData</p>
</div><p>Learn more about Strategic Intelligence</p>
<div class="lb-trans"><p>瞭解更多關於戰略情報</p>
</div><p>PsiQuantum quantum applications vice-president Sam Pallister said: “PsiQuantum is proud to work alongside the National Cancer Center Japan as we explore what utility-scale quantum computing will be able to deliver in designing new treatments for the benefit of researchers and patients.</p>
<div class="lb-trans"><p>PsiQuantum 量子應用副總裁 Sam Pallister 表示：“PsiQuantum 很自豪能與日本國立癌症中心合作，探索公用規模量子計算在設計新治療方案方面能夠帶來的益處，造福研究人員和患者。</p>
</div><p>“Once deployed, utility-scale quantum computers will accelerate research and development that transforms how we develop new medicines—and partnerships like these are critical for making sure providers are equipped to take full advantage of this technology.”</p>
<div class="lb-trans"><p>“一旦部署，公用規模的量子計算機將加速研究和開發，改變我們開發新藥物的方式——這樣的合作對於確保提供者能夠充分利用這一技術至關重要。”</p>
</div><p>National Cancer Center Hospital East’s global oncology director Dr Takayuki Yoshino said: “We are thrilled to partner with PsiQuantum on leveraging quantum computing technology to address some of the most pressing challenges in healthcare.</p>
<div class="lb-trans"><p>日本國立癌症中心醫院東部的全球腫瘤學主任高幸義博士表示：“我們很高興與 PsiQuantum 合作，利用量子計算技術解決醫療領域的一些最緊迫的挑戰。</p>
</div><p>“Together, our teams are poised to conduct innovative research and unlock new solutions at the intersection of pharmaceuticals, biotechnology, and quantum computing.”</p>
<div class="lb-trans"><p>“我們的團隊將共同開展創新研究，解鎖製藥、生物技術和量子計算交匯處的新解決方案。”</p>
</div>

PsiQuantum 與日本國家癌症中心合作開展量子計算